AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36316843 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 34679090 — intervention group
Group type: COMPARATOR
Intervention: Dissemination of written evidence-based practice recommendations
Number of subjects: 833
Study 34679090 — intervention group
Group type: COMPARATOR
Intervention: Access to a webinar-based knowledge broker in addition to the recommendations
Number of subjects: 833
Study 34679090 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual practice waitlist control
Number of subjects: 833
Study 33993302 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltegravir 400 mg twice daily
Number of subjects: 36
Study 33993302 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltegravir 400 mg + Lamivudine 150 mg twice daily
Number of subjects: 36
Study 33993302 — intervention group
Group type: COMPARATOR
Intervention: Control (Raltegravir alone)
Number of subjects: 36
Study 32578433 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple renal clearance estimates
Number of subjects: 154
Study 32578433 — intervention group
Group type: COMPARATOR
Intervention: Single renal clearance estimate
Number of subjects: 154
Study 36123682 — intervention group
Group type: EXPERIMENTAL
Intervention: Test 'A' (with food intake)
Number of subjects: 24
Study 36123682 — intervention group
Group type: COMPARATOR
Intervention: Test 'B' (without food intake)
Number of subjects: 24
Study 34052686 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress task (Trier Social Stress Task; TSST)
Number of subjects: 31
Study 34052686 — intervention group
Group type: COMPARATOR
Intervention: No-stress condition
Number of subjects: 31
Study 32036412 — intervention group
Group type: EXPERIMENTAL
Intervention: CC-486 300 mg daily (Formulation B)
Number of subjects: 0
Study 35789408 — intervention group
Group type: EXPERIMENTAL
Intervention: Neocate Junior‐Numil®
Number of subjects: 94
Study 33522102 — intervention group
Group type: EXPERIMENTAL
Intervention: High or escalating dose methotrexate
Number of subjects: 178
Study 33522102 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 178
Study 33522102 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 178
Study 33522102 — intervention group
Group type: EXPERIMENTAL
Intervention: Boys
Number of subjects: 178
Study 35888692 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthopedic surgeons
Number of subjects: 107
Study 35888692 — intervention group
Group type: COMPARATOR
Intervention: Untrained volunteers
Number of subjects: 107
Study 35888692 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthopedic surgeons with more than 100 procedures a year
Number of subjects: 107
Study 35888692 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthopedic surgeons with less surgical experience
Number of subjects: 107
Study 33845473 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol (15 mg/kg initially and then 7.5 mg/kg every 6 h)
Number of subjects: 58
Study 33845473 — intervention group
Group type: COMPARATOR
Intervention: Intravenous dextrose (control)
Number of subjects: 58
Study 33845473 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol
Number of subjects: 58
Study 35829783 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-quantity lipid-based nutrient supplements (SQ-LNS) with zinc (0, 5, or 10 mg) or dispersible tablets (5 mg zinc)
Number of subjects: 275
Study 35829783 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-quantity lipid-based nutrient supplements (SQ-LNS)
Number of subjects: 275
Study 35829783 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional zinc supplementation
Number of subjects: 275
Study 35503949 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS) device
Number of subjects: 125
Study 35503949 — intervention group
Group type: COMPARATOR
Intervention: Local anesthesia
Number of subjects: 125
Study 35503949 — intervention group
Group type: COMPARATOR
Intervention: No anesthesia
Number of subjects: 125
Study 34875282 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Activation (BA) via telemedicine
Number of subjects: 23
Study 33657052 — intervention group
Group type: EXPERIMENTAL
Intervention: DLT-SML
Number of subjects: 30
Study 33371027 — intervention group
Group type: EXPERIMENTAL
Intervention: Location-based remote messaging (tailored-to-place)
Number of subjects: 100
Study 33371027 — intervention group
Group type: COMPARATOR
Intervention: Standard remote messaging
Number of subjects: 100
Study 33371027 — intervention group
Group type: EXPERIMENTAL
Intervention: More intensive treatment for those not meeting PA goals
Number of subjects: 100
Study 35987783 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Acupuncture (MA)
Number of subjects: 200
Study 35987783 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-Acupuncture (EA)
Number of subjects: 200
Study 35987783 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm Acupuncture (WA)
Number of subjects: 200
Study 35987783 — intervention group
Group type: COMPARATOR
Intervention: Sham Acupuncture (SA)
Number of subjects: 200
Study 33360708 — intervention group
Group type: EXPERIMENTAL
Intervention: brief cognitive behavior group therapy (bCBGT)
Number of subjects: 50
Study 33360708 — intervention group
Group type: COMPARATOR
Intervention: psychoeducational-supportive therapy (PST)
Number of subjects: 50
Study 32428426 — intervention group
Group type: EXPERIMENTAL
Intervention: Values clarification methods (pros and cons, rating scales)
Number of subjects: 6744
Study 32428426 — intervention group
Group type: EXPERIMENTAL
Intervention: Mathematical models showing alignment of options with values
Number of subjects: 6744
Study 35678616 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily subcutaneous dalteparin
Number of subjects: 38
Study 32448788 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial diet rich in fiber, MUFA, n-6 and n-3 polyunsaturated fatty acids, polyphenols, vitamins D, E, and C (n=23)
Number of subjects: 49
Study 32448788 — intervention group
Group type: EXPERIMENTAL
Intervention: MUFA diet (n=26)
Number of subjects: 49
Study 32448788 — intervention group
Group type: COMPARATOR
Intervention: Multifactorial diet
Number of subjects: 49
Study 32448788 — intervention group
Group type: COMPARATOR
Intervention: MUFA diet
Number of subjects: 49
Study 35800262 — intervention group
Group type: EXPERIMENTAL
Intervention: Qinxiang Qingjie (QXQJ) oral solution
Number of subjects: 231
Study 35800262 — intervention group
Group type: COMPARATOR
Intervention: Oseltamivir phosphate granules
Number of subjects: 231
Study 32062324 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee joint sounds recorded during standing up from/sitting down on a bench
Number of subjects: 12
Study 32062324 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee joint sounds recorded during descending stairs
Number of subjects: 12
Study 32062324 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee joint sounds recorded during passive movement, 10% and 40% loading of the individual one repetition maximum
Number of subjects: 12
Study 35363128 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferinject (ferric carboxymaltose)
Number of subjects: 15
Study 35363128 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 32294054 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-use negative pressure wound therapy (sNPWT)
Number of subjects: 161
Study 32294054 — intervention group
Group type: COMPARATOR
Intervention: Traditional negative pressure wound therapy (tNPWT)
Number of subjects: 161
Study 35618385 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaching intervention focused on the quality of teacher-child interactions
Number of subjects: 281
Study 35618385 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaching intervention
Number of subjects: 281
Study 35618385 — intervention group
Group type: COMPARATOR
Intervention: Educator profiles (Average, Strong, Mixed)
Number of subjects: 281
Study 34987600 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild hypothermia therapy combined with monosialotetrahexosylganglioside (GM1)
Number of subjects: 90
Study 34987600 — intervention group
Group type: COMPARATOR
Intervention: Mild hypothermia therapy
Number of subjects: 90
Study 34987600 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment
Number of subjects: 90
Study 33033025 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week supervised exercise-based intervention comprising a progressive resistance exercise programme two times per week, a protein supplement after exercise, and a home-based walking programme based on daily step counts
Number of subjects: 100
Study 33033025 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week supervised exercise-based intervention
Number of subjects: 100
Study 33033025 — intervention group
Group type: COMPARATOR
Intervention: Standard oncological treatment
Number of subjects: 100
Study 35179506 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based medical advice authored by a physician
Number of subjects: 2305
Study 35179506 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based medical advice presented with an objective tone
Number of subjects: 2305
Study 35179506 — intervention group
Group type: COMPARATOR
Intervention: Discussion forum format
Number of subjects: 2305
Study 35179506 — intervention group
Group type: COMPARATOR
Intervention: Article format
Number of subjects: 2305
Study 35179506 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical skepticism
Number of subjects: 2305
Study 36083249 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile application tailored to Vietnamese cultural context, sending three messages per week
Number of subjects: 568
Study 36083249 — intervention group
Group type: COMPARATOR
Intervention: Control group mobile application sending general maternal and child health care messages
Number of subjects: 568
Study 32062801 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-aided diagnosis (CAD) system based on convolutional neural network (CNN)
Number of subjects: 149
Study 35964368 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based pulmonary rehabilitation (PR) exercise training program
Number of subjects: 96
Study 35964368 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 96
Study 33902306 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropathic pain at three months post-injury
Number of subjects: 1547
Study 33902306 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropathic pain at six months post-injury
Number of subjects: 1547
Study 33902306 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic pain without neuropathic characteristics at three months post-injury
Number of subjects: 1547
Study 33902306 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic pain without neuropathic characteristics at six months post-injury
Number of subjects: 1547
Study 33902306 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical disability associated with neuropathic pain at six months
Number of subjects: 1547
Study 33902306 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life associated with neuropathic pain at six months
Number of subjects: 1547
Study 32844185 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal multiple micronutrient (MM) supplementation
Number of subjects: 333
Study 32844185 — intervention group
Group type: COMPARATOR
Intervention: Maternal status (1-SD increment)
Number of subjects: 333
Study 34775830 — intervention group
Group type: EXPERIMENTAL
Intervention: Abrocitinib 200 mg
Number of subjects: 0
Study 34775830 — intervention group
Group type: EXPERIMENTAL
Intervention: Abrocitinib 100 mg
Number of subjects: 0
Study 34775830 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34775830 — intervention group
Group type: COMPARATOR
Intervention: Dupilumab
Number of subjects: 0
Study 33275804 — intervention group
Group type: EXPERIMENTAL
Intervention: Modern board and card games (n=6 in pilot study, n=12 in main study)
Number of subjects: 49
Study 33275804 — intervention group
Group type: EXPERIMENTAL
Intervention: Modern board and card games (n=12 in main study)
Number of subjects: 49
Study 33275804 — intervention group
Group type: COMPARATOR
Intervention: Standardized paper-and-pencil cognitive tasks (n=15 in main study)
Number of subjects: 49
Study 32183423 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey proteins
Number of subjects: 8
Study 32183423 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrins
Number of subjects: 8
Study 34748774 — intervention group
Group type: COMPARATOR
Intervention: 200 mg mirikizumab IV every 4 weeks
Number of subjects: 191
Study 34748774 — intervention group
Group type: COMPARATOR
Intervention: 600 mg mirikizumab IV every 4 weeks
Number of subjects: 191
Study 34748774 — intervention group
Group type: COMPARATOR
Intervention: 1000 mg mirikizumab IV every 4 weeks
Number of subjects: 191
Study 34748774 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 191
Study 34748774 — intervention group
Group type: EXPERIMENTAL
Intervention: IV-C (continuation of mirikizumab IV treatment)
Number of subjects: 191
Study 34748774 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg mirikizumab SC every 4 weeks
Number of subjects: 191
Study 33234019 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (0.1 g·kg‐1·d‐1)
Number of subjects: 38
Study 33234019 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.1 g·kg‐1·d‐1)
Number of subjects: 38
Study 33371627 — intervention group
Group type: EXPERIMENTAL
Intervention: AI triaging model
Number of subjects: 8005
Study 35970202 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical Cord Milking (UCM)
Number of subjects: 1780
Study 35970202 — intervention group
Group type: COMPARATOR
Intervention: Early Cord Clamping (ECC)
Number of subjects: 1780
Study 33798654 — intervention group
Group type: EXPERIMENTAL
Intervention: Voretigene neparvovec (VN; Luxturna) administered via bilateral subretinal injections in the original intervention group (OI).
Number of subjects: 31
Study 33798654 — intervention group
Group type: COMPARATOR
Intervention: Voretigene neparvovec (VN; Luxturna) administered via bilateral subretinal injections after 1 year in the delayed intervention group (DI).
Number of subjects: 31
Study 33798654 — intervention group
Group type: EXPERIMENTAL
Intervention: Voretigene neparvovec (VN; Luxturna) administered in OI group.
Number of subjects: 31
Study 33798654 — intervention group
Group type: COMPARATOR
Intervention: Voretigene neparvovec (VN; Luxturna) administered in DI group.
Number of subjects: 31
Study 32412094 — intervention group
Group type: EXPERIMENTAL
Intervention: VisualaseTM MRI-Guided Laser Ablation System
Number of subjects: 150
Study 35705263 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine group (group R) received additional SFICB using 40 mL of 0.375% ropivacaine.
Number of subjects: 86
Study 35705263 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine group (group R)
Number of subjects: 86
Study 35705263 — intervention group
Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 86
Study 34182547 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal surgical closure
Number of subjects: 0
Study 34182547 — intervention group
Group type: COMPARATOR
Intervention: Postnatal surgical closure
Number of subjects: 0
Study 35803624 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg daily azithromycin
Number of subjects: 0
Study 35803624 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg three-times-weekly azithromycin
Number of subjects: 0
Study 35803624 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study 32555025 — intervention group
Group type: EXPERIMENTAL
Intervention: Ahead of the Game program (intervention group)
Number of subjects: 350
Study 32555025 — intervention group
Group type: COMPARATOR
Intervention: Usual practice (control group)
Number of subjects: 350
Study 35042458 — intervention group
Group type: EXPERIMENTAL
Intervention: 7‐Fr central venous catheter (VC) group
Number of subjects: 92
Study 35042458 — intervention group
Group type: COMPARATOR
Intervention: Conventional chest tube (CT) group
Number of subjects: 92
Study 34526033 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine stat, prednisolone, azithromycin and naproxen (Group I)
Number of subjects: 336
Study 34526033 — intervention group
Group type: COMPARATOR
Intervention: Hydroxychloroquine and Lopinavir/Ritonavir (Group III)
Number of subjects: 336
Study 34526033 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine stat, azithromycin and naproxen (Group II)
Number of subjects: 336
Study 34526033 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (Group I)
Number of subjects: 336
Study 34526033 — intervention group
Group type: COMPARATOR
Intervention: Lopinavir/Ritonavir (Group III)
Number of subjects: 336
Study 33370763 — intervention group
Group type: EXPERIMENTAL
Intervention: Model 328-based peer education intervention for 8 weeks
Number of subjects: 150
Study 33370763 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (control group)
Number of subjects: 150
Study 32772583 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week physical rehabilitation program
Number of subjects: 84
Study 32772583 — intervention group
Group type: COMPARATOR
Intervention: Control group (12-week waiting period)
Number of subjects: 84
Study 36496259 — intervention group
Group type: EXPERIMENTAL
Intervention: ROTEM-guided treatment
Number of subjects: 60
Study 36496259 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 60
Study 34482042 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk of Relapse Assessment Scale (RRAS)
Number of subjects: 438
Study 32376809 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral gargling with an aroma solution
Number of subjects: 67
Study 32376809 — intervention group
Group type: COMPARATOR
Intervention: 0.9% normal saline (control)
Number of subjects: 67
Study 34473338 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcuminoids treatment (exact dosage and duration not specified)
Number of subjects: 0
Study 34473338 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 32970837 — intervention group
Group type: EXPERIMENTAL
Intervention: Late-absorbable sutures (group A)
Number of subjects: 150
Study 32970837 — intervention group
Group type: COMPARATOR
Intervention: Non-absorbable sutures (group B)
Number of subjects: 150
Study 32060130 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum zonulin levels in NCGS patients
Number of subjects: 86
Study 32060130 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported NCGS
Number of subjects: 86
Study 32060130 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat avoidance diet in HLA-DQ2/8-positive NCGS patients
Number of subjects: 86
Study 32060130 — intervention group
Group type: EXPERIMENTAL
Intervention: Zonulin levels diagnostic accuracy
Number of subjects: 86
Study 32060130 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic algorithm combining zonulin levels, symptoms, and gender
Number of subjects: 86
Study 615918485 — intervention group
Group type: EXPERIMENTAL
Intervention: Room 3.8m wide and 8m long
Number of subjects: 35
Study 615918485 — intervention group
Group type: COMPARATOR
Intervention: Room 11m wide and 9m long
Number of subjects: 35
Study 36484190 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture therapy based on 'gut-brain axis', treated with acupuncture at specific acupoints (Touwei, Shenting, Sishencong, Tianshu, Zhongwan, Zusanli), given once every other day, 3 times a week for 4 weeks, for 3 courses.
Number of subjects: 66
Study 36484190 — intervention group
Group type: COMPARATOR
Intervention: Routine rehabilitation training (Control group).
Number of subjects: 66
Study 34846698 — intervention group
Group type: EXPERIMENTAL
Intervention: Washed microbiota transplantation (WMT), frequency: once a day for three consecutive days
Number of subjects: 0
Study 34846698 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine treatment and WMT
Number of subjects: 0
Study 34846698 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment only
Number of subjects: 0
Study 35747189 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprepitant (125 mg orally on day 1, 80 mg on days 2-3) plus palonosetron (0.25 mg intravenously on day 1)
Number of subjects: 315
Study 35747189 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone (10 mg intravenously on day 1, 5 mg on days 2-3) plus palonosetron (0.25 mg intravenously on day 1)
Number of subjects: 315
Study 35747189 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone plus palonosetron
Number of subjects: 315
Study 35066948 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.4 mg/kg, maximum 30 mg/day) intravenously for 3 days
Number of subjects: 139
Study 35066948 — intervention group
Group type: COMPARATOR
Intervention: Conservative care only
Number of subjects: 139
Study 34118562 — intervention group
Group type: EXPERIMENTAL
Intervention: NT‐proBNP > 1500 ?mol/L
Number of subjects: 168
Study 34118562 — intervention group
Group type: EXPERIMENTAL
Intervention: Left atrial to aortic root ratio >2.1
Number of subjects: 168
Study 34118562 — intervention group
Group type: EXPERIMENTAL
Intervention: Normalized left ventricular end‐diastolic diameter > 1.9
Number of subjects: 168
Study 34118562 — intervention group
Group type: EXPERIMENTAL
Intervention: Early transmitral peak velocity (E peak) > 1 m/sec
Number of subjects: 168
Study 33172546 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy combined with Saccharomyces boulardii
Number of subjects: 124
Study 35616109 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate ADT (n=56)
Number of subjects: 261
Study 35616109 — intervention group
Group type: COMPARATOR
Intervention: Delayed ADT (n=69)
Number of subjects: 261
Study 35616109 — intervention group
Group type: COMPARATOR
Intervention: No prior ADT group
Number of subjects: 261
Study 35607258 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy (CRT)
Number of subjects: 56
Study 35607258 — intervention group
Group type: COMPARATOR
Intervention: Non-specific cognitive-training (NSCT)
Number of subjects: 56
Study 34037772 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-skeletonized harvesting of the left internal mammary artery (LIMA)
Number of subjects: 235
Study 34037772 — intervention group
Group type: COMPARATOR
Intervention: Pedicled harvesting of the left internal mammary artery (LIMA)
Number of subjects: 235
Study 36064432 — intervention group
Group type: EXPERIMENTAL
Intervention: HTO combined with PRP
Number of subjects: 74
Study 36064432 — intervention group
Group type: COMPARATOR
Intervention: HTO combined with hyaluronic acid
Number of subjects: 74